Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Beactica Therapeutics - Precision |
Description | Committed To The Fight Against Beactica Therapeutics is a precision oncology company developing novel, life-saving small molecule therapeutics to treat genetically defined cancers |
Keywords | N/A |
WebSite | beactica.com |
Host IP | 217.70.37.6 |
Location | Sweden |
Site | Rank |
US$1,104,077
Last updated: 2023-05-11 07:22:31
beactica.com has Semrush global rank of 9,586,568. beactica.com has an estimated worth of US$ 1,104,077, based on its estimated Ads revenue. beactica.com receives approximately 127,394 unique visitors each day. Its web server is located in Sweden, with IP address 217.70.37.6. According to SiteAdvisor, beactica.com is safe to visit. |
Purchase/Sale Value | US$1,104,077 |
Daily Ads Revenue | US$1,020 |
Monthly Ads Revenue | US$30,575 |
Yearly Ads Revenue | US$366,894 |
Daily Unique Visitors | 8,493 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
beactica.com. | A | 3598 | IP: 217.70.37.6 |
beactica.com. | NS | 3600 | NS Record: ns2.loopia.se. |
beactica.com. | NS | 3600 | NS Record: ns1.loopia.se. |
beactica.com. | MX | 3600 | MX Record: 1 beactica-com.mail.protection.outlook.com. |
beactica.com. | TXT | 3600 | TXT Record: MS=ms12660770 |
beactica.com. | TXT | 3600 | TXT Record: v=spf1 include:kundspf.loopia.se a:mx2.bahnhof.se include:_spf.staysecuregroup.com include:spf.protection.outlook.com ~all |
About us Öppna Our Background Our Vision and Culture Our Team Careers Science Öppna Pipeline Powerful Discovery Synthetic Lethality Platform Success Partnering Öppna Drug Discovery Partnerships Research Consortia Services Investors Resources & Media Öppna Press Releases Publications Events Recent Coverage Videos Contact Committed To The Fight Against Cancer Beactica Therapeutics is a precision oncology company developing novel, life-saving small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Explore more Latest Press Beactica Therapeutics to present update on LSD1 programme at the AACR Annual Meeting... 11 apr 2023 Read more Latest Publication Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase 22 feb 2021 Read more Latest Event Hippo Pathway Targeted Drug Development Summit 2023 23 maj 2023 Read more "Beactica has a rich and unique history of creating impact and has always been dedicated to excellence and |
HTTP/1.1 301 Moved Permanently Transfer-Encoding: chunked Location: https://beactica.com/ Server: Microsoft-IIS/10.0 Generator: Easyweb CMS (https://www.easyweb.se) X-XSS-Protection: 1 X-Powered-By: ASP.NET Date: Thu, 04 Nov 2021 07:35:17 GMT HTTP/2 405 allow: GET, POST location: https://www.beactica.com/ server: Microsoft-IIS/10.0 strict-transport-security: max-age=2592000 generator: Easyweb CMS (https://www.easyweb.se) x-xss-protection: 1 x-powered-by: ASP.NET date: Thu, 04 Nov 2021 07:35:18 GMT |
Domain Name: BEACTICA.COM Registry Domain ID: 573845655_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2021-08-02T08:39:14Z Creation Date: 2006-08-29T09:02:58Z Registry Expiry Date: 2022-08-29T09:02:58Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.LOOPIA.SE Name Server: NS2.LOOPIA.SE DNSSEC: unsigned >>> Last update of whois database: 2021-10-21T07:16:22Z <<< |